The Democratic Republic of Congo (DRC) is now ten years from the official end of what some call Africa’s first world war. The transition from conflict to sustainable development is never easy, especially for the poor and most vulnerable. While indicators are improving, DRC’s maternal mortality is still 846 deaths per 100,000 live births. What can be done to end preventable newborn, child, and maternal mortality in DRC?
Investing in strong health systems is imperative to ending preventable maternal, newborn, and child deaths. Please join us for a discussion on the impact and importance of health systems strengthening in advancing maternal, newborn, and child survival around the world.
Join the conversation on Twitter using #SaveMomsandKids and follow MSH's policy handle, @MSHACTS.
Karen Cavanaugh, Director, Office of Health Systems, USAID
Robert Clay, Vice President of Global Health, Save the Children US
International Women's Day 2015 Event
Women and girls experience widespread inequalities in socioeconomic power, education, and gender-based violence, resulting in lack of access to health services (including reproductive health and family planning services), which lead to detrimental health outcomes. For example, every day 800 women die from preventable causes related to pregnancy and childbirth, and women and girls face increased vulnerability to HIV/AIDS.
Health systems stengthening drives our response to the tuberculosis epidemic. In over 30 countries MSH is working with international, national, and local partners to strengthen the capacity of health systems, national TB programs, and health managers to improve the lives of those affected by TB and prevent the spread of disease. Our work addresses all elements of the health system: service delivery; leadership and governance; medical products, vaccines, and technologies; health financing; health information; and human resources.
Integrated community case management (iCCM) increases access to treatment to those beyond the reach of health facilities and has the potential to more equitably address the three largest causes of child mortality in sub-Saharan Africa. Since 2000, the use of iCCM to deliver pneumonia, malaria and diarrhea treatments to children under 5 has dramatically increased. It is increasingly being used to treat neonatal infections and child malnutrition.